Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis

Journal of Clinical Investigation

Volumn 97, Issue 4, 1996, Pages 979-987

  Freedman, Jane E ^a   Loscalzo, Joseph ^a   Benoit, Stephen E ^b   Valeri, C Robert ^a   Barnard, Marc R ^b   Michelson, Alan D ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

blood platelet; cerebral embolism and thrombosis; child; glutathione peroxidase; nitric oxide

Indexed keywords

NITRIC OXIDE; PADGEM PROTEIN; REACTIVE OXYGEN METABOLITE;

ARTERY THROMBOSIS; ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION;

EID: 0030028604     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118522     Document Type: Article

References (63)

1. Stamler, J., M.E, Mendelsohn, P. Amarante, D. Smick, N. Andon, P.F Davies, J.P. Cooke, and J. Loscalzo. 1989. N-Acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ. Res 65:789-795.
2. Cooke, J.P., J. Stamler, N. Andon, P F. Davies, G. McKinley, and J. Loscalzo. 1990. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am. J. Physiol. 259:H804-H812.
3. de Graaf, J.C., J.D. Banga, S Moncada, R.M.J. Palmer. P.G. de Groot, and J.J Sixma. 1992. Nitric oxide functions as an inhibitor of platelet adhesion under flow conditions. Circ. 85:2284-2290.
4. Ignarro, L.J., R.E. Byrns, G.M. Buga, and K S Wood. 1987. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 61 866-879.
5. Mellion, T.B., L.J Ignarro, E H. Ohlstein, E.G. Pontecorvo, A.L. Hyman, and P.J. Kadowitz. 1981. Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood. 57:946-955.
6. Michelson, A D., S.E. Benoit, M.I. Furman, W.L. Breckwoldt, M.J. Rohrer, M.R. Barnard, and J. Loscalzo. 1996 Effects of endothelium-derived relaxing factor/nitric oxide on platelet surface glycoproteins Am J. Physiol. In press.
7. Shultz, P.J , and L. Raij. 1992 Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J. Clin. Invest. 90:1718-1725.
8. Radomski, M.W., M.J. Palmer, and S. Moncada. 1987. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun 148:1482-1489.
9. Huie, R.E., and S. Padmaja. 1993. The reaction of NO with Superoxide. Free Radical Res Commun 18 195-199.
10. Radi., R., J.S. Beckman, K Bush, and B.A. Freeman 1991. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of Superoxide and nitric oxide. J. Biol. Chem. 266.4244-4250.
11. Rubbo, H., R. Radi, M Trujillo, R. Telleri, B Kalyanaraman, S. Barnes, M. Kirk, and B. Freeman. 1994 Nitric oxide regulation of Superoxide and peroxynitrite-dependent lipid peroxidation. J Biol Chem. 269:26066-26075.
12. Noronha-Dutra, A.A., M.M. Epperlein, and N Woolf. 1993. Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide-mediated killing FEBS Lett. 321L:59-62
13. Simon, D., J S. Stamler, E. Loh, J. Loscalzo, S.A. Francis, and M.A Creager. 1995. Effect of nitric oxide synthase inhibition on bleeding times in humans. J. Cardiovasc. Pharm 26:339-342.
14. Dougherty, J.H., D.E. Levy, and B.B. Weksler. 1977. Platelet activation in acute cerebral ischemia: Serial measurement of platelet function in cerebrovascular disease. Lancet. 1:821-824
15. Loscalzo, J. 1985. N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J. Clin. Invest 76:703-708.
16. Mendelsohn, M E., S. O'Neill, D. George, and J Loscalzo. 1990. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem 265.19028-19034.
17. Stenberg, P E., R P. McEver, M.A. Shuman, Y.V. Jacques, and D.F Bainton. 1985. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J. Cell Biol. 101:880-886.
18. Bevilacqua, M., E Butcher, B. Furie, M. Gallatin, M. Gimbrone, J. Harlan, K. Kishimoto, L. Lasky, R. McEver, J. Paulson. et al. 1991. Selectins: a family of adhesion receptors. Cell. 67:233.
19. Schlossman, S.F., L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C Morimoto, J. Ritz, S. Shaw, R.L. Silverstein, T.A. Springer, et al. 1994. CD antigens 1993. Blood. 83:879-880
20. Hsu-Lin, S.-C., C.L. Berman, B.C Furie, D. August, and B. Furie. 1984 A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets J. Biol Chem 259:9121-9126.
21. McEver, R.P. 1990. Properties of GMP-140, an inducible granule membrane protein of platelets and endothelium. Blood Cells. 16:73-80.
22. Gatter, K.C., J.L. Cordell, H. Turley, A. Heryet, N. Kieffer, D. J. Anstee, and D.Y. Mason. 1988. The immunohistological detection of platelets, megakaryocytes and thrombi in routinely pi ocessed specimens. Histopathology. 13 257-267
23. Shattil, S.J., J.A. Hoxie, M. Cunningham, and L.F. Brass. 1985. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol. Chem. 260:11107-11114.
24. Kestin, A S., C.R. Valeri, S F. Khuri, J Loscalzo, P A. Ellis, H. MacGregor, V. Birjiniuk, H Ouimet, B Pasche, M.J. Nelson, S.E. Benoit, L.J. Rodino, M.R. Barnard, and A.D. Michelson. 1993. The platelet function defect of cardiopulmonary bypass Blood 82:107-117.
25. Coller, B.S., E.I. Peerschke, L E. Scudder, and C A. Sullivan. 1983. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood. 61:99-110.
26. Michelson, A.D., J, Loscalzo, B. Melnick, B.S. Coller, and R.I. Handin. 1986. Partial characterization of a binding site for von Willehrand factor on glycocalicin. Blood. 67:19-26.
27. Michelson, A.D., P.A. Ellis, M.R. Barnard, G.B. Matic, A.F. Viles, and A.S. Kestin. 1991. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, ADP or an in vivo wound. Blood. 77.770-779
28. Shattil, S.J., M Cunningham, and J.A Hoxie. 1987. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 70:307-315.
29. Michelson, A.D., and M.R. Barnard. 1990. Plasmin-induced redistribution of platelet glycoprotein Ib. Blood. 76:2005-2010.
30. Yamamoto, N., N.J. Greco, M R. Barnard, K. Tanoue, H. Yamazaki, G.A Jamieson, and A.D. Michelson. 1991. Glycoprotein Ib (GPIb)-dependent and GPIb-independent pathways of thrombin-induced platelet activation. Blood. 77:1740-1748.
31. Hawiger, J., S. Parkinson, and S. Timmons. 1980 Prostacyclin inhibits mobilization of fibrinogen-binding sites on human ADP- and thrombin-treated platelets Nature (Lond.). 2831:195-198
32. Michelson, A.D. 1994. Platelet activation by thrombin can be directly measured in whole blood through the use of the peptide GPRP and flow cytometry: methods and clinical applications. Blood Coag. Fibrimnlysis 5:121-131.
33. Born, G. V., and M.J Cross. 1963. The aggregation of blood platelets. J. Physiol (Lond ). 168:178-195.
34. Stamler, J.S., O. Jaraki, J. Osborne, D I. Simon, J Kcaney, J. Vita, D. Singel, C.R. Valeri, and J. Loscalzo. 1992. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci USA 89.7674-7677.
35. Pai, T.G., W.J. Payne, and J. LeGall. 1987. Use of a chemiluminescence detector for quantitation of nitric oxide produced in assays of denitrifying enzymes. Anal. Biochem. 166:150-157.
36. 2 release from human granulocytes during phagocytosis I. Documentation, quantitation, and some regulating factors. J. Clin. Invest. 55:945-955.
37. Stamler, J.S., J.A. Osborne, O. Jaraki, L.E. Rabbani, M. Mullins, D. Singel, and J. Loscalzo. 1993. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 91:308-318
38. Starkebaum, G , and J.M. Harlan. 1986. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine J. Clin Invest. 77:1370-1376.
39. Pascual, P., E. Martinez-Lara, J.A. Barcena, J. Lopez-Barea, and F. Toribio. 1992 Direct assay of glutathione peroxidase activity using high-performance capillary electrophoresis. J. Chromatography. 581:49-56
40. Alfthan, G., and J. Kumpulainen. 1982. Determination of selenium in small volumes of blood plasma and serum by electrothermal atomic absorption spectrometry. Anal. Chim. Acta. 140:221-227.
41. Stocker, R., V W. Bowry, and B. Frei 1991. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol Proc. Natl. Acad. Sci. USA. 88:1646-1650.
42. Frei, B., L England, and B.N. Ames. 1989. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad Sci. USA. 86:6377-6381
43. Freedman, J.E., B. Frei, G.N. Welch, and J. Loscalzo 1995. Glutathione peroxidase prevents the inactivation of nitric oxide and restores the inhibition of platelet function by S-nitrosothiols. J. Clin. Invest. 96:394-400.
44. Marcus, A.J., and L.B. Safier. 1993. Thromboregulation' multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J. 7. 516-522.
45. Radomski, M.W., R.M.J. Palmer, and S. Moncada. 1987. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J. Pharmacol 92:181-187
46. Stamler, J.S , D.E. Vaughan, and J. Loscalzo. 1989. Syoergistic disaggregation of platelets by tissue-type plasminogen activator, prostaglandin E1, and nitroglycerin. Circ Res. 65.796-804.
47. Keaney, J.F., J. Puyana, S. Francis, J.F. Loscalzo, J.S. Stamler, and J. Loscalzo 1994. Methylene blue reverses endotoxin-induced hypotension. Circ. Res. 74:1121-1125.
48. Riela, A.R., and E.S Roach 1993 Etiology of stroke in childhood. J Child Neurology. 8:201-220.
49. Ioannidis, I., and H. de Groot. 1993. Cytotoxicity of nitric oxide in Fu5 rat hepatoma cells: evidence for co-operative action with hydrogen peroxide. Biochem. J. 296:341-345.
50. Principe, D.D., A. Menichelli, W. De Matteir, S. Di Giulio, M Giodani, I. Savmi, and A. Finazzi Agro. 1991. Hydrogen peroxide is an intermediate in the platelet activation cascade triggered by collagen, but not thrombin. Thromb Res. 62.365-375.
51. Leoncini, G., B. Aprile, and M. Maresca. 1993 p-Bromophenacyl bromide potentiates hydrogen peroxide formation in human platelets challenged by thrombin and inhibits aggregation. Biochem. Mol. Biol. Internat. 29:317-325.
52. Marcus, A.J., S.T. Silk, L.B. Safier, and H.L. Ullman. 1977. Superoxide production and reducing activity in human platelets. J. Clin. Invest. 59:149-158.
53. Levine, P.H , R.S. Weniger, J. Simon, K.L. Scoon, and N.I. Krinsky. 1976. Leukocyte-platelet interaction. Release of hydrogen peroxide by granulocytes as a modulator of platelet release reactions. J. Clin. Invest. 57:955-963.
54. Rodvien, R., J N Lindon. and P.H. Levine 1976. Physiology and ultrastructure of the blood platelet following exposure to hydrogen peroxide. Br. J. Haematol. 33:19-26.
55. Shatos, M.A., J.M. Doherty, and J.C. Hoak. 1991. Alteration in human vascular endothelial cell function by oxygen free radicals. Platelet adherence and prostacyclin release. Arieroscler. Thromb. 11:594-601.
56. Maddipati, K.R., and L.J. Marnett. 1987. Characterization of the major hydroperoxide-reducing activity of human plasma. J. Biol. Chem. 262(36): 17398-17403
57. Violi, F., A. Ghiselli, L. Iuliano, C. Alessandri, C. Cordova, and F. Balsano 1988. Influence of hydroxyl radical scavengers on platelet function. Haemostasis. 18:91-98.
58. Pryor, W.A 1994. Free radicals and lipid peroxidation: what they are and how they got that way. In Natural Antioxidants in Human Health and Disease. B Frei, editor. Academic Press, Inc., San Diego, CA. 1-24.
59. Buczynski, A , B. Wachowicz, K. Dedziora-Kornatowska, W. Tkaczewski, and J. Kedziora. 1993. Changes in antioxidant enzyme activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 100:223-228.
60. Portal, B.C , MJ. Richard, H S. Faure, A.J. Hadjian, and A.E Favier. 1995. Altered antioxidant status and increased lipid peroxidation in children with cystic fibrosis. Am. J. Clin Nutr. 61:843-847.
61. Smith, A.M., L W. Chen, and M.R. Thomas. 1995. Selenate fortification improves selenium status of term infants fed soy formula. Am. J. Clin Nutr. 61. 44-47.
62. Avissar, N., J.C Whitin, P.Z. Allen, D.D Wagner, P. Liegey, and H.J. Cohen. 1989. Plasma selenium-dependent glutathione peroxidase. Cell of origin and secretion. J Biol. Chem. 264:15850-15855
63. Avissar, N., D.B. Ornt, Y. Yagil, S. Horowitz, R.H. Watkins, E.A. Kerl, K. Takahashi, I.S. Palmer, and H J. Cohen. 1994. Human kidney proximal tubules are the main source of plasma glutathione peroxidase. Am. J. Physiol. 266:C367-C375.